Literature DB >> 3109897

In vitro activity of RO 15-8074 and RO 19-5247.

T Valle, E Jalanko, L Scheinin, O V Renkonen.   

Abstract

The in vitro activity of RO 15-8074 (cefetamet) and RO 19-5247, new oral cephalosporins, was compared with that of amoxicillin, cephalexin, cefaclor, cefuroxime and erythromycin against 292 clinical isolates using the agar dilution method. Both RO 15-8074 and RO 19-5247 were very active against Proteus mirabilis, Neisseria gonorrhoeae, Haemophilus influenzae and Streptococcus pyogenes, but less active against Staphylococcus saprophyticus and Enterobacter cloacae. RO 19-5247 was more active than RO 15-8074 against Haemophilus influenzae and Streptococcus viridans.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109897     DOI: 10.1007/bf02018201

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  1 in total

1.  In-vitro activity of Ro-15-8074, a new oral cephalosporin.

Authors:  M Peeters; P Piot
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

  1 in total
  3 in total

1.  Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.

Authors:  K E Aldridge; D D Schiro; C V Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

2.  Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria.

Authors:  J Wüst; U Hardegger
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

Review 3.  Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.